There are days when we sit at our computer reading news stories or analyst reports and start laughing out loud. Today is one of those days. The first chuckle came reading the various analysis of MannKind (NASDAQ: MNKD) recent earnings report. Yep it’s finally dawning on people that hey maybe it’s not such a good idea to make something for dollars, sell it for pennies and spend a ton of money in the process.
Another good chuckle happened when we read an article about CellNovo, who in case you haven’t heard is an OmniPod wannabe. The writer . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.